The management of residual masses after chemotherapy in metastatic seminoma

Autor: R, Ravi, J, Ong, R T, Oliver, D F, Badenoch, C G, Fowler, W F, Hendry
Rok vydání: 1999
Předmět:
Zdroj: BJU international. 83(6)
ISSN: 1464-4096
Popis: To review our experience in management of residual masses after chemotherapy for metastatic seminoma.The study comprised a review of 107 patients with metastatic seminoma, treated with initial chemotherapy from 1978 to 1996. Forty-three patients had residual masses detected by computed tomography after chemotherapy, while 64 achieved a complete response. Residual masses were classified radiologically as3 cm or/=3 cm and as well- or poorly defined. Of the patients with residual masses, 19 underwent surgery, while 24 were observed.Viable cancer was present in six of 11 patients with well-defined residual masses of/=3 cm (positive histology in three of six undergoing surgery and site relapses in three of five observed), one of 14 patients with poorly defined masses of/=3 cm (negative histology in nine undergoing surgery and site relapse in one of five observed), and in none of 17 patients with residual masses of3 cm (negative histology in four undergoing surgery and no site relapses in 13 observed; one additional patient in this group died from treatment complications).Patients with a complete response after chemotherapy, a residual mass of3 cm and a poorly defined residual mass of/=3 cm can be observed, reserving intervention for recurrent or progressive disease. Well-defined residual masses of/=3 cm should be resected because there is a 55% likelihood of persistent tumour.
Databáze: OpenAIRE